Thermo Fisher Scientific Inc. Share Price Buenos Aires S.E.
Equities
TMOD
ARBCOM4601F7
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27 USD | -.--% | -.--% | -.--% |
Sales 2024 * | 43.01B 3,392B | Sales 2025 * | 46.08B 3,634B | Capitalization | 227B 17,908B |
---|---|---|---|---|---|
Net income 2024 * | 6.11B 482B | Net income 2025 * | 7B 552B | EV / Sales 2024 * | 5.84 x |
Net Debt 2024 * | 23.99B 1,892B | Net Debt 2025 * | 19.18B 1,513B | EV / Sales 2025 * | 5.34 x |
P/E ratio 2024 * |
37.6
x | P/E ratio 2025 * |
32
x | Employees | 122,000 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.27% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific Inc.
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 31/10/01 |
Director of Finance/CFO | 57 | 31/05/01 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 31/10/01 |
C. Harris
BRD | Director/Board Member | 67 | 29/03/12 |
Ruby Chandy
BRD | Director/Board Member | 62 | 28/02/22 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.88% | 192B | |
+17.88% | 136B | |
+28.46% | 108B | |
+1.67% | 64.07B | |
+17.56% | 52.1B | |
+7.04% | 51.87B | |
+10.88% | 44.33B | |
+5.62% | 36.75B | |
+28.77% | 31.71B |
- Stock Market
- Equities
- TMO Stock
- TMOD Stock